{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170530",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "48612",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208694s000lbl.pdf",
              "date": "20170601",
              "type": "Label"
            },
            {
              "id": "48628",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208694Orig1s000ltr.pdf",
              "date": "20170602",
              "type": "Letter"
            },
            {
              "id": "51477",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N208694_cetirizine_Orig_WR.pdf",
              "date": "20150915",
              "type": "Pediatric Written Request"
            },
            {
              "id": "51478",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N208694_cetirizine_Amend_1.pdf",
              "date": "20160329",
              "type": "Pediatric Amendment 1"
            },
            {
              "id": "52417",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/136_208694 cetirizine clinical resub both.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "52418",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/135_208694 cetirizine clinical both.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "52419",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/137_208694 cetirizine clinpharm both.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "52420",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/138_208694 cetirizine statistical both.pdf",
              "date": "20180101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "54733",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208694Orig1s000TOC.html",
              "date": "20180702",
              "type": "Review"
            },
            {
              "id": "54734",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208694Orig1s000TOC.html",
              "date": "20180702",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20200205",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "61806",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208694Orig1s006ltr.pdf",
              "date": "20200206",
              "type": "Letter"
            },
            {
              "id": "61847",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208694s006lbl.pdf",
              "date": "20200207",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA208694",
      "sponsor_name": "HARROW EYE",
      "openfda": {
        "application_number": [
          "NDA208694"
        ],
        "brand_name": [
          "ZERVIATE"
        ],
        "generic_name": [
          "CETIRIZINE"
        ],
        "manufacturer_name": [
          "Harrow Eye, LLC"
        ],
        "product_ndc": [
          "82667-015"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "OPHTHALMIC"
        ],
        "substance_name": [
          "CETIRIZINE"
        ],
        "rxcui": [
          "2119476",
          "2119481"
        ],
        "spl_id": [
          "5828ae2e-81de-a88b-e063-6294a90a24b3"
        ],
        "spl_set_id": [
          "6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59"
        ],
        "package_ndc": [
          "82667-015-24"
        ],
        "nui": [
          "N0000000190",
          "N0000175587"
        ],
        "pharm_class_moa": [
          "Histamine H1 Receptor Antagonists [MoA]"
        ],
        "pharm_class_epc": [
          "Histamine-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "YO7261ME24"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ZERVIATE",
          "active_ingredients": [
            {
              "name": "CETIRIZINE HYDROCHLORIDE",
              "strength": "EQ 0.24% BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION/DROPS",
          "route": "OPHTHALMIC",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}